PPD
Clinical Trial Organization & Support / Clinical Development / Laboratory Services – CRO
Goals & Objectives
PPD is a top-5 global CRO at the forefront of direct-to-patient (DTP) services and decentralized clinical trials (DCT). It sought to clarify its DCT offering and continue fueling the industry’s burgeoning trend toward decentralization.
Strategic Approach
That’s Nice collaborated with PPD’s subject matter experts to develop a retargeting campaign, identifying PPD’s team as trailblazers in this emerging approach to clinical trials. The strategy also further emphasized the PPD’s DCT approach’s ability to reduce recruitment costs, increase enrolment rates and retention, and improve patients’ trial experience overall.
Meeting & Exceeding KPIs
The PPD campaigns significantly outperformed original client expectations for engagement and middle-of-funnel growth. PPD was acquired by ThermoFisher Scientific in late 2021 for a record $17.4 Billion, but has continued its dedicated relationship with That’s Nice to maintain performance that has exceeded annual goals for its DCT business.
